Tweeted by @AIR
Drugs Controller General of India (DCGI) has granted Emergency Use
Authorisation to COVID-19 vaccine Corbevax for children between 12-18
years of age group. The vaccine has been developed by Hyderabad-based
pharmaceutical company Biological E Ltd which country's first
indigenously developed Receptor Binding Domain protein sub-unit COVID-19
vaccine.
Earlier, the vaccine had received emergency use authorisation for the
adult population in December last year. The Corbevax vaccine is
administered through an intramuscular route with two doses scheduled 28
days apart and is stored at 2 to 8 degree Celsius temperature.
Talking to AIR News, Member, Health, NITI
Aayog Dr VK Paul said, with the emergency use approval to Corbevax, the
country has now two Covid-19 vaccines for children including Covaxin
which is already in use for the children aged 15 to 18 years.
Social media is bold.
Social media is young.
Social media raises questions.
Social media is not satisfied with an answer.
Social media looks at the big picture.
Social media is interested in every detail.
social media is curious.
Social media is free.
Social media is irreplaceable.
But never irrelevant.
Social media is you.
(With input from news agency language)
If you like this story, share it with a friend!
We are a non-profit organization. Help us financially to keep our journalism free from government and corporate pressure
0 Comments